Robert Guigley currently serves as the Chief Commercial Officer at Freenome, focusing on improving cancer screening accessibility through innovative blood draw methods. Previously, Guigley held the Chief Commercial Officer position at DELFI Diagnostics and Invitae, where responsibilities included strategic market expansion and leading commercial functions during a pivotal company sale. At Ambry Genetics, Guigley drove the commercial strategy and enhanced market access, achieving significant revenue improvements. Earlier experience includes leadership roles at Omada Health and Counsyl, and foundational sales positions at Quest Diagnostics and AstraZeneca, complemented by an MBA from Boston University's Questrom School of Business and a BS from the University of Pittsburgh.
This person is not in any teams
This person is not in any offices